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Introduction
Melanoma has become a major global public health concern. Over the last years, the frequency of melanoma new cases in Western countries has risen quickly, and this disease has be-
come one of fatal cancers [1, 2]. Hyperthermia is one of the most im-
portant cancer treatment methods [3]. Hyperthermia is usually defined 
as heating of a tissue to temperature ranges from 42 to 50 °C [4-6]. 
For the destruction of a tumor, various thermal energy delivery meth-
Original
ABSTRACT
Background: Gold nanoshells can be tuned to absorb a particular wavelength of 
light. As a result, these tunable nanoparticles (NPs) can efficiently absorb light and 
convert it to heat. This phenomenon can be used for cancer treatment known as pho-
tothermal therapy. In this study, we synthesized Fe3O4@Au core-shell NPs, magneti-
cally targeted them towards tumor, and used them for photothermal therapy of cancer.
Objective: The main purpose of this research was to synthesize Fe3O4@Au core-
shell NPs, magnetically target them towards tumor, and use them for photothermal 
therapy of cancer. 
Material and Methods: In this experimental study, twenty mice received 2 
× 106 B16-F10 melanoma cells subcutaneously. After tumors volume reached 100 
mm3,the mice were divided into five groups including a control group, NPs group, 
laser irradiation group, NPs + laser group and NPs + magnet + laser group. NPs were 
injected intravenously. After 6 hours, the tumor region was irradiated by laser (808 
nm, 2.5 W/cm2, 6 minutes). The tumor volumes were measured every other day. 
Results: The effective diameter of Fe3O4@Au NPs was approximately 37.8 nm. 
The average tumor volume in control group, NPs group, laser irradiation group, NPs 
+ laser irradiation group and NPs + magnet + laser irradiation group increased to 
47.3, 45.3, 32.8, 19.9 and 7.7 times, respectively in 2 weeks. No obvious change in 
the average body weight for different groups occurred. 
Conclusion: Results demonstrated that magnetically targeted nano-photothermal 
therapy of cancer described in this paper holds great promise for the selective de-
struction of tumors. 
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ods including microwave, radiofrequency, fo-
cused ultrasound and laser have been devel-
oped [7-9]. Hyperthermia therapy using laser 
beams is one of the current tools to fight can-
cer [4, 10, 11]. Photothermal therapy (PTT) 
is a minimally invasive therapy that typically 
involves the usage of photothermal agents and 
laser light [12, 13]. Generally, for minimizing 
laser absorption in other tissues and for in-
creasing laser penetration, near-infrared (NIR) 
wavelengths around 650-900 nm are used [9]. 
Metal NPs absorb laser light and act as pho-
tothermal agents because of their enhanced 
absorption cross sections [6]. Advantages of 
gold nanoparticles (Au NPs) in PTT include 
a strong light absorption cross section of Au 
NPs (due to surface plasmon resonance), and 
biocompatibility, and ease of linking of Auto 
proteins and antibodies [14, 15]. Three major 
shapes of Au NPs used in PTT include spheres, 
rods and core-shells. Gold nanoshells general-
ly consist of a silica core and a thin gold shell. 
In addition to silica, different cores have been 
used to take advantage of such a nanomate-
rial [16, 17]. For example, Fe3O4@Au core-
shell is used to produce multifunctional NPs 
[18-21]. Advantages of Fe3O4@Au NP as a 
multifunctional nanoparticle include its strong 
absorption cross section due to the presence of 
Au as a photothermal agent, the ability of such 
a nanomaterial as a contrast agent in both CT 
scan and MRI modalities and its capability to 
be used in the magnetic targeting of a tumor 
[18, 21-23]. By adjusting the core diameter and 
shell thickness, the absorption peak of Fe3O4@
Au NPs can be tuned to NIR region [6, 17]. In 
this study, Fe3O4@Au NPs were synthesized 
and characterized using transmission electron 
microscopy (TEM), dynamic laser light scat-
tering (DLS) and UV-vis spectrophotometer. 
Thereafter, Fe3O4@Au NPs were exposed to a 
continuous-wave (CW) diode laser at a wave-
length of 808 nm to assess the photothermal 
effect of the NPs. Finally, this nanostructure 
was used for magnetically targeted photother-
mal therapy in mice bearing melanoma tumor. 
For this purpose, after intravenous injection 
of Fe3O4@Au NPs, they were accumulated in 
tumor region using a 3500 Gauss magnet, and 
then tumor site was irradiated with laser beam.
Material and Methods
This study is an experimental study. Material 
and methods that was used in this study was 
as follow.
Chemicals
Iron (III) chloride hexahydrate (>99%), iron 
(II) chloride tetrahydrate (>99%), methanol 
(99.9%), ammonia (32%) and toluene (>99%) 
were purchased from Merck. 3-Amino-prop-
yltrimethoxysilane (97%) and Gold (III) chlo-
ride solution were purchased from Fluka and 
Sigma, respectively.
Fe3O4@Au Core-shell NPs Synthesis 
Fe3O4@Au core-shell NPs were synthesized 
according to the method recently published 
by Montazerabadi et al, [24]. Briefly, Fe3O4@
Au NPs were synthesized using an alteration 
of the co-precipitation technique of Massart 
[25]. First, 12.5 mL of NH3 (2 M) was added 
drop wise to a 2:1 solution of FeCl3.6H2O and 
FeCl2.4H2O under mechanical stirring. When 
the addition was augmented, the sediment was 
isolated by an external magnet, washed three 
times with methanol, diffused in 50 mL of 
toluene and kept as the source of Fe3O4 col-
loidal solution. Then, 3-Aminopropyl trime-
thoxysilane (APTMS) (25 µL) was added to 
12.5 mL of Fe3O4 NPs and sonicated for 30 
minutes. The solution then was heated at 60 
°C for 4 hours in an oven. The sediment was 
separated with a magnet, washed three times 
with methanol to eliminate extra toluene and 
APTMS, and then dispersed in methanol.
To form Au shells on the surface of Fe3O4 
NPs, Au NPs with a diameter of 3.5 nm were 
synthesized as detailed in the literature [26] 
and immobilized onto the surface of APTMS-
functionalized Fe3O4 NPs. In this regard, 4 mL 
of APTMS-functionalized Fe3O4 NPs (51.5 
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mM Fe) in methanol was added drop wise to 
a 25 mL solution of undiluted Au NPs (0.198 
mM Au). Next, 4mL of methanol and 10mL 
of water were added to maximize the cover-
age of Au NPs on the surface of Fe3O4 NPs. 
After 2 hours of stirring at room temperature, 
Au NPs were immobilized onto the surface of 
Fe3O4 NPs. The resulting NPs were separated 
with an external magnet, washed three times 
with deionized water and dispersed in 15 mL 
of deionized water. At the end, 0.011 g of chlo-
roauric acid was added to 15mL of a prepared 
solution of Au immobilized on the surface of 
Fe3O4 NPs under sonication. To finalize shell 
formation, 0.4 mL (78.9 mM) of ascorbic acid 
was added to the final solution. After 2 hours 
of incubation, a contiguous and complete Au 
shell was constructed on the surface of Fe3O4 
NPs.
Characterization Methods
Before any use in experimental tests, Fe3O4@
Au NPs were characterized. Zeiss LEO 906 
transmission electron microscope (TEM) was 
used for analyzing the morphological charac-
teristics of NPs. In this regard, NPs were sus-
pended in deionized water and sonicated for 
10 minutes. A small drop of suspension was 
mounted onto a carbon-coated copper grid and 
allowed to vaporize. Thereafter, the thoroughly 
dried grid was observed under a transmission 
electron microscope at 120 KV. Furthermore, 
the hydrodynamic size distribution of NPs was 
determined using dynamic laser light scatter-
ing (DLS) with a Malvern Zetasizer, NANO 
ZS (Malvern Instruments Limited, UK). UV-
visible (UV-vis) absorption spectrophotomet-
ric measurements were performed by a sin-
gle-beam UV-vis spectrometer, Agilent 8453, 
using quartz cells of 1 cm path length and DI 
water as the reference at room temperature.
Photothermal Conversion of Fe3O4@
Au NPs Solutions 
Representative samples with 0 µg/mL, 12.5 
µg/mL, 25 µg/mL, 37.5 µg/mL and 50 µg/mL 
of Fe3O4@Au NPs in 300 µL deionized water 
were pelleted in a 96-well cell culture plate. 
A home-built 808 nm continuous wave diode 
laser was used as a light source. Samples at 
each Fe3O4@Au NPs concentration were irra-
diated with power densities of 0.9 W/cm2, 1.8 
W/cm2, 2.5 W/cm2 and 3.5 W/cm2. Tempera-
ture variation was determined using a ther-
mocouple probe Type K with measurements 
recorded at 30-second intervals. The temper-
ature measurements were performed using a 
thermometer model ST 8891E manufactured 
by Standard Instruments Co. (China). The 
thermocouple probe was placed vertically at 
the center of each sample. The initial tempera-
tures of samples were recorded for the first 10 
seconds before irradiation of the NIR laser; 
each sample was then irradiated for 360 sec-
onds, and temperature variation curves were 
plotted.
Cell Culture and Tumor Induction
Cell Line
Mouse malignant melanoma cell line B16/
F10 (C540) which can grow in C57BL/6 strain 
mouse was purchased from the National Cell 
Bank of Iran (NCBI, Pasteur Institute of Iran). 
The cells were cultured in Dulbecco’s Modi-
fied Eagle’s Medium (DMEM) supplemented 
with 4 mM L-glutamine, 4.5 g/l glucose, 10% 
fetal bovine serum (FBS) and antibiotics (100 
μg/ml streptomycin and 100 μg/ml penicillin). 
The cells were maintained in culture flasks at 
37°C in a humidified incubator containing 5% 
CO2. When the confluency of melanoma cells 
reached 80%, the cells were washed with phos-
phate buffer saline (PBS) and detached from 
the bottom of the flask with PBS containing 
0.25% trypsin and 0.03% EDTA, and then pel-
leted by brief centrifugation. The supernatant 
was removed, cell pellets were resuspended in 
PBS, and the cell was counted.
Animals
Male C57BL/6 mice, at age of 4-6 weeks 
(20-25 gr) obtained from Pasteur Institute of 
Iran were used for in-vivo experiments. The 
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mice were housed in a light controlled house 
at 25°C and humidity of 55% with free access 
to water and food. All animal procedures were 
performed in adaptation with the protocol con-
structed by the committee of an animal study 
in Isfahan University of Medical Sciences. A 
12/12 dark/lightcycle was followed as men-
tioned in the animal vivarium. 
Twenty male C57BL/6 mice were chosen to 
serve as recipient mice for tumor inoculation. 
Mice were maintained for 1 week to acclimate 
to the environment before the experiment. 
C57BL/6 mice were implanted with 2 × 106 
B16-F10 melanoma cells in 100 μL of PBS 
subcutaneously in the right flank using a dis-
posable tuberculin syringe. Primary touchable 
tumors were developed on days 6-7. When the 
tumor volume reached 100 mm3, the tumor-
bearing mice were selected for treatment. For 
laser treatment process, the overlying hair on 
the tumor was shaved and all mice were anes-
thetized with a mixture of xylazine and ket-
amine. The treated mice were kept in separate 
cages, and tumor volume measurements were 
made every other day.
NIR Laser Irradiation of Tumors
After tumor volume reached 100 mm3, the 
tumor-bearing mice were randomly assigned 
into 5 groups and each group contained 4 
mice. These groups include: control group, la-
ser irradiation group, NPs group, NPs + laser 
irradiation group and NPs + magnet + laser 
irradiation group. Mice in control and laser 
irradiation group were injected intravenously 
with 100 μl of saline. Mice in NPs + laser irra-
diation group and NPs + magnet + laser irradi-
ation group were injected intravenously with 
100 μl of Fe3O4@Au NPs (concentration of 
150 μg Au/ml). The mice in these two groups 
were kept for 6 hours for the accumulation of 
Fe3O4@Au NPs in the tumor. The last group 
was considered for magnetic targeting. In this 
group, a 3500 Gauss magnet was placed on 
mice skin in the tumor region. This magnet at-
tracted the Fe3O4 core of NPs and accumulated 
NPs in the tumor. Then, the tumors were irra-
diated using an NIR laser (808 nm diode laser) 
with a laser power density of 2.5 W/cm2 for 6 
minutes. The day of treatment was day zero. 
Thereafter, tumor volumes in all mice were 
measured every other day. Tumor volumes 
were calculated using this formula [27-29]: 
Tumor volume = (π/6×(tumor width)2×(tumor length)
To assess the photothermal therapy efficien-
cy in different groups, the growth inhibition 
rate (IR) was calculated using the following 
equation [30, 31]:





= − ×     
Where V is the average tumor volume in 
each group, and Control is the average tumor 
volume in the control group.
To evaluate the toxicity of NPs, the body 




Fe3O4@Au NPs were successfully synthe-
sized and characterized using TEM, DLS and 
UV-vis spectroscopy. Figure 1(a) shows a TEM 
image of Fe3O4@Au NPs. The dark region in 
the center and the peripheral brighter region 
in the TEM image correspond to Fe3O4 core 
and Au shell, respectively [32]. As it can be 
seen from TEM images, Fe3O4@Au NPs are 
approximately spherical. The UV-vis spectro-
scopic result for these NPs is shown in Figure 
1(b). Synthesized Fe3O4@Au NPs have an ab-
sorption peak at the wavelength of about 650 
nm. Figure 1(c) shows the NPs size distribu-
tion resulted from DLS analysis. According to 
Figure 1(c), the effective diameter of Fe3O4@
Au NPs was approximately 37.8 nm.
Photothermal Conversion of Fe3O4@
Au NPs Solutions 
To evaluate the photothermal effects of 
Fe3O4@Au NPs, the temperature variation of 
five different concentrations of NPs was mea-
32
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sured under NIR laser irradiation at four pow-
er densities and irradiation time 6 minutes (as 
described in section photothermal conversion 
of Fe3O4@Au NPs solutions). The tempera-
ture variation for different Au concentrations 
and different laser power densities are shown 
in Figure 2.
When these NPs were irradiated using an 
808 nm laser, the laser absorbed energy is con-
verted to heat energy that resulted in tempera-
ture elevation of NPs solutions (Figure 2). For 
equal laser power densities, solutions contain-
ing Fe3O4@Au NPs achieved higher tempera-
tures compared with PBS samples free of NPs. 
Laser irradiation with power density of 3.5 W/
cm2 produced average temperature variation 
of 7.85, 10.20, 12.75, 15.30 and 23.25. When 
Au concentration was of 0 µg/mL (PBS only), 
12.5 µg/mL, 25 µg/mL, 37.5 µg/mL and 50 µg/
mL, respectively. For an identical nanoparticle 
concentration of 50 µg/mL, increasing laser 
power density resulted in increased tempera-
ture variation from 6.9 °C for a power density 
of 0.9 W/cm2 to 11.2 °C, 17.9 °C and 23.25°C 
for power densities of 1.8, 2.5 and 3.5 W/cm2, 
respectively.
NIR Laser Irradiation of Tumors
The treatment was performed as mentioned 
in section NIR laser irradiation of tumors. Af-
ter treating the mice with described various 
protocols, the tumor volume in all mice was 
measured every other day. Figure 3 shows the 
tumor volume in different groups following 
the treatment.
As seen in Figure 3, tumor volume in control 
group increased rapidly while tumor growth in 
NPs + magnet + laser irradiation group was 
appropriately controlled. The average tumor 
volume in control group increased from 105 
mm3 to 4965 mm3 which was 47.3 times larger 
than what it was initially. In NPS group, laser 
irradiation group, NPs + laser irradiation group 
and NPs + magnet + laser irradiation group, 
the average tumor volume increased from 103 
mm3 to 4671 mm3 (45.3 times increase), from 
105 mm3 to 3451 mm3 (32.8 times increase), 
from 100 mm3 to 1993 mm3 (19.9 times in-
crease) from 99 mm3 to 768 mm3 (7.7 times 
increase), respectively. Skin damage was de-
tected in the NPs + magnet + laser group due 
to the large temperature change during laser 
exposure. The damage completely disap-
Figure 1: (a) Transmission electron microscopy (TEM) image of Fe3O4@Au nanoparticles (NPs). 
(b) The absorption spectra of NPs. (c) NPs size distribution resulted from dynamic laser light 
scattering (DLS).
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peared within two weeks after the treatment.
After 2 weeks post treatment, the average 
tumor volume in both NPs + laser and NPs + 
magnet + laser groups was significantly lower 
than the average of tumor volume in control 
group (P = 0.028 < 0.05). 
The inhibition rate graphs for different 
groups are depicted in Figure 4. As shown in 
Figure 4, the inhibition effect of Fe3O4@Au 
NPs + magnet + laser on the tumor was ob-
vious. After the treatment course (2 weeks), 
the average inhibition rate in NPs + magnet 
+ laser group was 83.5%. The average inhibi-
tion rates in NPs group, laser group and NPs 
+ laser group were 6%, 26% and 57%, respec-
tively.
To evaluate the toxicity of NPs, the body 
weight of mice were measured every other 
Figure 2: Temperature variation for different Au concentrations and different laser power den-
sities. Figures 2 (a) to (e) correspond to Au concentrations of 0 µg/mL, 12.5 µg/mL, 25 µg/mL, 
37.5 µg/mL and 50 µg/mL, respectively.
Figure 3: Tumor growth curves vs. time 
per days after treatment. Various graphs 
in this figure show the results of control, 
nanoparticles (NPs), laser, NPs + laser and 
NPs + magnet + laser groups
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day. The body weights of mice in different 
groups are shown in Figure 5 demonstrating 
no obvious change in the average body weight 
for different groups.
Discussion
This study demonstrated the efficacy of us-
ing Fe3O4@Au core-shell NPs as a potent 
photothermal agent for cancer photothermal 
therapy.
The absorption spectra of Fe3O4@Au NPs, 
Au and Fe3O4 NPs are shown in Figure 1(b). 
The absorption peak of 560 nm and 640 nm 
was observed for Au NPs and Fe3O4@Au NPs, 
respectively. The absorption peak for Fe3O4@
Au NPs showed the peak broadening and a 
red-shift, which is usually observed in other 
Au bimetallic core-shell systems [13, 33].
When these NPs were irradiated using an 
808 nm laser, the laser absorbed energy is 
converted to heat energy resulting in tempera-
ture elevation of NPs solutions (Figure 2). For 
equal laser power densities, solutions con-
taining Fe3O4@Au NPs achieved higher tem-
peratures compared with PBS samples with-
out NPs. The temperature variation was both 
concentration and laser power density depen-
dent. For all power densities at the beginning 
of laser exposure, the temperature increased 
rapidly and then reached a steady state. This 
pattern of increasing temperature as a result 
of increasing laser exposure time has been ob-
served by other scientists [34-36].
To evaluate the efficiency of designed treat-
ment protocol, twenty mice were implanted 
with melanoma cells. The average tumor vol-
ume in control group, NPs group, laser irradia-
tion group and NPs + laser irradiation group 
increased 47.3, 45.3, 32.8 and 19.9 times, re-
spectively. When the magnetic targeting was 
applied to the NPs + magnet + laser irradiation 
group, the average tumor volume increased 
only 7.7 times in 2 weeks. This finding shows 
that the magnetic targeting in cancer photo-
thermal therapy using Fe3O4@Au NPs result-
ed in increasing the effectiveness of cancer 
treatment and tumor growth suppression. Li 
et al. took advantage of magnetic targeting for 
remote drug delivery using oligonucleotides-
gated silica shell-coated Fe3O4@Au Core-
Shell Nanotrisoctahedra and NIR light [22]. 
Their result indicated that magnetic targeting 
resulted in NPs accumulation in tumor and the 
effectiveness of treatment increased.
Two weeks after treatment, the average inhi-
bition rate in NPs + magnet + laser group was 
83.5%. The average inhibition rates in NPs 
group, laser group and NPs + laser group were 
Figure 4: The inhibition rate graphs for dif-
ferent groups of this study. The graphs corre-
spond to control, nanoparticles (NPs), laser, 
NPs + laser and NPs + magnet + laser groups.
Figure 5: The body weight of mice in differ-
ent groups. The graphs correspond to con-
trol, nanoparticles (NPs), laser, NPs + laser 
and NPs + magnet + laser groups
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6%, 26% and 57%, respectively. Compared to 
control group, it could be concluded that the 
inhibition rate of NPs + magnet + laser group 
was apparent.
For the evaluation of the toxicity of NPs, the 
body weights of mice were measured every 
other day (Figure 5). As shown in Figure 5, 
there was no obvious change in the average 
body weight in different groups. It should be 
considered that during two weeks after the 
treatment day, mice in different groups are 
able to preserve their body weights (Figure 5), 
indicating that NPs alone, laser alone, NPs+ 
laser and NPs + magnet + laser are non-toxic 
to the mice.
Conclusion
In this study, we synthesized Fe3O4@Au 
core-shell NPs. The super paramagnetic Fe3O4 
cores can act as magnetic targeting while Au 
shells function as NIR photothermal therapy 
converter to ablate tumor tissue. This study 
indicates the potential of Fe3O4@Au NPs in 
magnetic targeted tissue heating.
Temperature produced by photothermal 
treatment depends on both NPs concentration 
and laser power density. The designed treat-
ment protocol in this study destroyed implant-
ed melanoma tumors in C57BL/6 mice. Re-
sults show tumor volume in NPs + magnet + 
laser group was significantly smaller than that 
of the control group. Therefore, photothermal 
therapy using Fe3O4@Au core-shell NPs is an 
effective method for cancer treatment.
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